S. Vito Al Torre, Italy

Giorgio Bais



 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Giorgio Bais: A Pioneer in Polymorphic Detection

Introduction: Giorgio Bais, an innovator based in S. Vito Al Torre, Italy, has made significant contributions to the field of pharmaceutical sciences with his patented technology. His work focuses on the detection of polymorphs, a critical aspect in the development and manufacturing of pharmaceuticals.

Latest Patents: Giorgio Bais holds a patent for a "Method of detecting polymorphs using synchrotron radiation." This groundbreaking method utilizes X-ray technology produced by a synchrotron source, enabling the detection of specific polymorphs that are present in minute quantities within mixtures of polymorphic compounds. The technique not only enhances the resolution of these mixtures but also has profound applications in the pharmacy industry, ensuring quality and efficacy in drug development.

Career Highlights: As a dedicated professional, Giorgio is associated with Zetacube S.r.l., where he applies his expertise in advanced detection methods to further innovations in the pharmaceutical sector. His advancements help propel the company into a leading role in the market by providing solutions that address complex challenges in drug formulation.

Collaborations: Giorgio has had the opportunity to collaborate with talented individuals such as Roberto Brescello and Livius Cotarca. These partnerships enhance the innovation process, combining diverse skills and knowledge to develop efficient solutions in polymorph detection.

Conclusion: Giorgio Bais exemplifies the spirit of innovation in the realm of pharmaceutical sciences through his significant patent and contributions to the detection of polymorphs. His collaboration with experts and his role at Zetacube S.r.l. showcases a commitment to advancing technologies that bolster drug development, making a lasting impact on the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…